Tuesday, October 28, 2014
75 Years after Receiving the Nobel Prize
Ceremony for Gerhard Domagk – a Pioneer in the History of Medicine
75
years ago, he was awarded the Nobel Prize for discovering sulfonamides:
Bayer researcher Gerhard Domagk. With this medication, he significantly
contributed to fighting tuberculosis. To recognize his achievements,
the University of Greifswald, Germany, held a Gerhard Domagk celebration
on the day of the 75th anniversary of the Nobel Prize – with support
from the Bayer Foundation.
“75 years ago, Gerhard Domagk received the Nobel Prize –
that’s a wonderful occasion to recall how much our lives, our economic
power and our well-being are dependent on progress – and thus on people
who tread new ground, tackle so far unresolved challenges and follow
their inspiration with courage,” stressed Thimo V. Schmitt-Lord,
Managing Director of the Bayer Foundation. “Progress is unthinkable
without these pioneers. This is why we support people who work on
progress and promote talented young scientists with the programs of our
foundations – truly in line with our corporate mission ‘Bayer: Science
For A Better Life.’”
Who was Gerhard Domagk? At the event, his grandson Prof. Dirk Domagk presented his grandfather’s life and work. Domagk discovered a new class of drugs against infectious diseases caused by bacteria, which later saved the lives of thousands of people. After three years of continuous trails, the first antibiotic developed by Domagk at Bayer was launched on the market in 1935 under the brand name “Prontosil”. In 1939, Domagk was awarded the Nobel Prize in Medicine for his discovery.
Current challenges in medicine
During the festive event, the university’s medical school not only presented the extraordinary Bayer researcher Domagk, but also current areas of research and challenges in medicine. On the following day, the staff also hosted a “Day of Science in Medicine” that centered on research and doctoral theses.
Who was Gerhard Domagk? At the event, his grandson Prof. Dirk Domagk presented his grandfather’s life and work. Domagk discovered a new class of drugs against infectious diseases caused by bacteria, which later saved the lives of thousands of people. After three years of continuous trails, the first antibiotic developed by Domagk at Bayer was launched on the market in 1935 under the brand name “Prontosil”. In 1939, Domagk was awarded the Nobel Prize in Medicine for his discovery.
Current challenges in medicine
During the festive event, the university’s medical school not only presented the extraordinary Bayer researcher Domagk, but also current areas of research and challenges in medicine. On the following day, the staff also hosted a “Day of Science in Medicine” that centered on research and doctoral theses.
No comments:
Post a Comment